Simcere Pharmaceuticals Group’s Strategic Collaboration on Multiple Bispecific Antibodies

Ropes & Gray advised Simcere Pharmaceutical Group in a strategic collaboration with Netherlands-based Merus to obtain an exclusive license to develop and commercialize in China three…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Michael Patrini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here